Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Humphreys

Showing results (391-400 of 450) with videos related to

Pageof 45
Sort By:
Lancet (London, England)|February 5, 2022
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet CommissionKeith Humphreys, Chelsea L Shover, Christina M Andrews, et al.
Breast Cancer Research and Treatment|February 23, 2013
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variantOfure Obazee, Christina Justenhoven, Stefan Winter, et al.
Plos One|August 11, 2011
The genetic structure of the Swedish populationKeith Humphreys, Alexander Grankvist, Monica Leu, et al.
American Journal of Human Genetics|June 25, 2013
Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma riskJia Nee Foo, Karin E Smedby, Nicholas K Akers, et al.
Breast Cancer Research and Treatment|November 1, 2011
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variantChristina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Breast Cancer Research and Treatment|September 28, 2010
A combined analysis of genome-wide association studies in breast cancerJingmei Li, Keith Humphreys, Tuomas Heikkinen, et al.
Breast Cancer Research : BCR|November 11, 2010
A genome-wide association scan on estrogen receptor-negative breast cancerJingmei Li, Keith Humphreys, Hatef Darabi, et al.
Breast Cancer Research and Treatment|February 21, 2013
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replicationRebecca Hein, Dieter Flesch-Janys, Norbert Dahmen, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
Pageof 45

Showing results (391-400 of 450) with videos related to

Sort By:
Pageof 45
Lancet (London, England)|February 5, 2022
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet CommissionKeith Humphreys, Chelsea L Shover, Christina M Andrews, et al.
Breast Cancer Research and Treatment|February 23, 2013
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variantOfure Obazee, Christina Justenhoven, Stefan Winter, et al.
Plos One|August 11, 2011
The genetic structure of the Swedish populationKeith Humphreys, Alexander Grankvist, Monica Leu, et al.
American Journal of Human Genetics|June 25, 2013
Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma riskJia Nee Foo, Karin E Smedby, Nicholas K Akers, et al.
Breast Cancer Research and Treatment|November 1, 2011
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variantChristina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Breast Cancer Research and Treatment|September 28, 2010
A combined analysis of genome-wide association studies in breast cancerJingmei Li, Keith Humphreys, Tuomas Heikkinen, et al.
Breast Cancer Research : BCR|November 11, 2010
A genome-wide association scan on estrogen receptor-negative breast cancerJingmei Li, Keith Humphreys, Hatef Darabi, et al.
Breast Cancer Research and Treatment|February 21, 2013
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replicationRebecca Hein, Dieter Flesch-Janys, Norbert Dahmen, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
Pageof 45